Jeremy Rich
Deputy Director for Research & Chief Scientific Officer at UNC Lineberger Comprehensive Cancer Center · University of North Carolina Hospitals
Credentials: · · · · · ·
History
- 1998–2001
Neurology
1997–1998- 1993–1994
1989–1993
1985–1989
Research
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
Nature · 2006 · Last of 9 authors · 5,084 citations
Cancer stem cells in glioblastoma
Review · Genes & Development · 2015 · Last of 5 authors · 1,303 citations
Bevacizumab plus irinotecan in recurrent glioblastoma multiforme
Journal of Clinical Oncology · 2007 · 1,096 citations
61 papers
52 papers
48 papers · 22 as a resident
- DB
46 papers
43 papers
- BP
41 papers · 13 as a resident
34 papers
- JV
34 papers
Grants
- 2024–2031
Targeting Glioblastoma Stem Cells
National Cancer Institute · R35
Contact PI · $1.9M · Univ of North Carolina Chapel Hill
- 2024–2029
Targeting Amino Acid Metabolism in Glioblastoma
National Institute of Neurological Disorders and Stroke · R01
Contact PI · $1.7M · Univ of North Carolina Chapel Hill
- 2024–2029
Metabolic Control of Translation in Glioblastoma
National Institute of Neurological Disorders and Stroke · R01
Contact PI · $1.7M · Univ of North Carolina Chapel Hill
- 2022–2027
Metabolic Regulation of Glioblastoma Epitranscriptomics
National Cancer Institute · R01
PI · $2.9M · University of Pittsburgh at Pittsburgh